Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 12904

1.

Asymmetric Synthesis of Highly Functionalized Tetrahydropyran DPP-4 Inhibitor.

Xu F, Zacuto MJ, Kohmura Y, Rosen J, Gibb A, Alam M, Scott J, Tschaen D.

Org Lett. 2014 Sep 30. [Epub ahead of print]

PMID:
25269068
[PubMed - as supplied by publisher]
2.

Incidence of Cancer and Mortality in Patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Trial.

Green A, Ramey DR, Emneus M, Iachina M, Stavem K, Bolin K, McNally R, Busch-Sørensen M, Willenheimer R, Egstrup K, Kesäniemi YA, Ray S, Basta N, Kent C, Pedersen TR.

Am J Cardiol. 2014 Aug 27. pii: S0002-9149(14)01710-X. doi: 10.1016/j.amjcard.2014.08.016. [Epub ahead of print]

PMID:
25267716
[PubMed - as supplied by publisher]
3.

Challenges and Priorities for Research: A Report From the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health (NIH) Working Group on Thrombosis in Pediatric Cardiology and Congenital Heart Disease.

McCrindle BW, Li JS, Manlhiot C, Tweddell JS, Giglia TM, Massicotte MP, Monagle P, Krishnamurthy R, Mahaffey KW, Michelson AD, Verdun N, Almond CS, Newburger JW, Brandão LR, Esmon CT, Manco-Johnson MJ, Ichord R, Ortel TL, Chan AK, Portman R, Rose M, Strony J, Kaltman JR.

Circulation. 2014 Sep 30;130(14):1192-203. doi: 10.1161/CIRCULATIONAHA.113.008428. No abstract available.

PMID:
25266860
[PubMed - in process]
4.

Identification of the pharmacophore of the CC Chemokine-binding proteins Evasin-1 and -4 using phage display.

Bonvin P, Dunn SM, Rousseau F, Dyer DP, Shaw J, Power CA, Handel TM, Proudfoot AE.

J Biol Chem. 2014 Sep 29. pii: jbc.M114.599233. [Epub ahead of print]

PMID:
25266725
[PubMed - as supplied by publisher]
Free Article
5.

Virologic Resistance Analysis from a Phase II Study of MK-5172 Combined with Peginterferon/Ribavirin In Treatment-Naive Patients with HCV-Genotype 1 Infection.

Howe AY, Black S, Curry S, Ludmerer SW, Liu R, Barnard RJ, Newhard W, Hwang PM, Nickle D, Gilbert C, Caro L, DiNubile MJ, Mobashery N.

Clin Infect Dis. 2014 Sep 28. pii: ciu696. [Epub ahead of print]

PMID:
25266289
[PubMed - as supplied by publisher]
6.

A novel evaluation method of survival motor neuron protein as a biomarker of spinal muscular atrophy by imaging flow cytometry.

Arakawa M, Arakawa R, Tatsumi S, Aoki R, Saito K, Nomoto A.

Biochem Biophys Res Commun. 2014 Sep 27. pii: S0006-291X(14)01715-X. doi: 10.1016/j.bbrc.2014.09.087. [Epub ahead of print]

PMID:
25264200
[PubMed - as supplied by publisher]
7.

Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: Insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER).

Jones WS, Tricoci P, Huang Z, Moliterno DJ, Harrington RA, Sinnaeve PR, Strony J, Van de Werf F, White HD, Held C, Armstrong PW, Aylward PE, Chen E, Patel MR, Mahaffey KW.

Am Heart J. 2014 Oct;168(4):588-96. doi: 10.1016/j.ahj.2014.06.017. Epub 2014 Jul 4.

PMID:
25262270
[PubMed - in process]
8.

Anti-inflammatory actions of Chemoattractant Receptor-homologous molecule expressed on Th2 by the antagonist MK-7246 in a novel rat model of Alternaria alternata elicited pulmonary inflammation.

Gil MA, Caniga M, Woodhouse JD, Eckman J, Lee HH, Salmon M, Naber J, Hamilton VT, Sevilla RS, Bettano K, Klappenbach J, Moy L, Correll CC, Gervais FG, Siliphaivanh P, Zhang W, Zhang-Hoover J, McLeod RL, Cicmil M.

Eur J Pharmacol. 2014 Sep 23. pii: S0014-2999(14)00673-6. doi: 10.1016/j.ejphar.2014.09.021. [Epub ahead of print]

PMID:
25261040
[PubMed - as supplied by publisher]
9.

The c-Met Inhibitor MSC2156119J Effectively Inhibits Tumor Growth in Liver Cancer Models.

Bladt F, Friese-Hamim M, Ihling C, Wilm C, Blaukat A.

Cancers (Basel). 2014 Aug 19;6(3):1736-52. doi: 10.3390/cancers6031736.

PMID:
25256830
[PubMed]
Free Article
10.

Development of In Vitro-In Vivo Correlation for Extended-Release Niacin After Administration of Hypromellose-Based Matrix Formulations to Healthy Volunteers.

Kesisoglou F, Rossenu S, Farrell C, Van Den Heuvel M, Prohn M, Fitzpatrick S, De Kam PJ, Vargo R.

J Pharm Sci. 2014 Sep 24. doi: 10.1002/jps.24179. [Epub ahead of print]

PMID:
25256703
[PubMed - as supplied by publisher]
11.

Cost-Effectiveness Analysis parallel to a Randomized Controlled Trial comparing Vertical Scar Reduction (VSR) and Inverted T-Shaped reduction (ITR) mammoplasty.

Thoma A, Kaur MN, Tsoi B, Ziolkowski N, Duku E, Goldsmith CH.

Plast Reconstr Surg. 2014 Sep 24. [Epub ahead of print]

PMID:
25255113
[PubMed - as supplied by publisher]
12.

Enlarging the repertoire of therapeutic monoclonal antibodies platforms: domesticating half molecule exchange to produce stable IgG4 and IgG1 bispecific antibodies.

Yang X, Ambrogelly A.

Curr Opin Biotechnol. 2014 Sep 22;30C:225-229. doi: 10.1016/j.copbio.2014.09.001. [Epub ahead of print] Review.

PMID:
25254943
[PubMed - as supplied by publisher]
13.

Immunohistological Description of Nongestational Ovarian Choriocarcinoma in Two Female Mice With Conditional Loss of Trp53 Driven by the Tie2 Promoter.

Castiglioni V, Ghahremani MF, Goossens S, De Maglie M, Ardizzone M, Haigh JJ, Radaelli E.

Vet Pathol. 2014 Sep 24. pii: 0300985814551581. [Epub ahead of print]

PMID:
25253064
[PubMed - as supplied by publisher]
14.

Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients.

Gilbert CL, Stek JE, Villa G, Klopfer SO, Martin JC, Schödel FP, Bhuyan PK.

Vaccine. 2014 Sep 20. pii: S0264-410X(14)01262-6. doi: 10.1016/j.vaccine.2014.09.015. [Epub ahead of print]

PMID:
25252192
[PubMed - as supplied by publisher]
15.

Synthesis of [3 H], [13 C3 , 15 N], and [14 C]SCH 900567: an inhibitor of TNF-α (tumor necrosis factor alpha) converting enzyme (TACE).

Ren S, Hesk D, McNamara P, Koharski D, Borges S.

J Labelled Comp Radiopharm. 2014 Sep 23. doi: 10.1002/jlcr.3229. [Epub ahead of print]

PMID:
25251383
[PubMed - as supplied by publisher]
16.

Efficacy of a Cathepsin K Inhibitor in a Preclinical Model for Prevention and Treatment of Breast Cancer Bone Metastasis.

Duong LT, Wesolowski GA, Leung P, Oballa R, Pickarski M.

Mol Cancer Ther. 2014 Sep 23. pii: molcanther.0253.2014. [Epub ahead of print]

PMID:
25249554
[PubMed - as supplied by publisher]
17.

Discovery of MK-3697: A selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia.

Roecker AJ, Reger TS, Mattern MC, Mercer SP, Bergman JM, Schreier JD, Cube RV, Cox CD, Li D, Lemaire W, Bruno JG, Harrell CM, Garson SL, Gotter AL, Fox SV, Stevens J, Tannenbaum PL, Prueksaritanont T, Cabalu TD, Cui D, Stellabott J, Hartman GD, Young SD, Winrow CJ, Renger JJ, Coleman PJ.

Bioorg Med Chem Lett. 2014 Aug 26. pii: S0960-894X(14)00885-3. doi: 10.1016/j.bmcl.2014.08.041. [Epub ahead of print]

PMID:
25248679
[PubMed - as supplied by publisher]
18.

Low carbohydrate diet from plant or animal sources and mortality among myocardial infarction survivors.

Li S, Flint A, Pai JK, Forman JP, Hu FB, Willett WC, Rexrode KM, Mukamal KJ, Rimm EB.

J Am Heart Assoc. 2014 Sep 22;3(5). pii: e001169. doi: 10.1161/JAHA.114.001169.

PMID:
25246449
[PubMed - in process]
Free Article
19.

Cost-utility analysis of genotype-guided antiplatelet therapy in patients with moderate-to-high risk acute coronary syndrome and planned percutaneous coronary intervention.

Patel V, Lin FJ, Ojo O, Rao S, Yu S, Zhan L, Touchette DR.

Pharm Pract (Granada). 2014 Jul;12(3):438. Epub 2014 Sep 4.

PMID:
25243032
[PubMed]
Free PMC Article
20.

Interrogating two schedules of the AKT inhibitor MK-2206 in patients with advanced solid tumors incorporating novel pharmacodynamic and functional imaging biomarkers.

Yap TA, Yan L, Patnaik A, Tunariu N, Biondo A, Fearen I, Papadopoulos K, Olmos D, Baird RD, Delgado LM, Tetteh E, Beckman RA, Lupinacci L, Riisnaes R, Decordova S, Heaton SP, Swales K, deSouza NM, Leach MO, Garrett MD, Sullivan DM, de Bono JS, Tolcher A.

Clin Cancer Res. 2014 Sep 19. pii: clincanres.0868.2014. [Epub ahead of print]

PMID:
25239610
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk